Hone Health key facts
as of Oct 2026- Developer of a telemedicine kit designed to help men and women lead longer, healthier lives.
- Hone Health is valued at approximately $312.8M as of Oct 2026 (last reported valuation).
- It has raised $48.5M; the latest was Later Stage VC ($32.8M) in Jan 2025.
- Notable investors include FJ Labs, Gaingels, Calm Ventures, Tribe Capital, Makai VC — 31 tracked in total.
- Status: Privately Held (backing).
Hone Health's last reported valuation, Jan 2025. Nothing priced has surfaced since.
- ·The complete investor list: 31 names
- ·Watch Hone Health: the Monday email on marks, rounds and moves
Hone Health funding rounds
No funding rounds for Hone Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Hone Health
31+Membership and data by Private Market View
Hone Health valuation
Hone Health's last reported valuation was $313 million in Jan 2025. No priced round, secondary trade or fund mark has surfaced since.
Hone Health investors
31 investors are on record for Hone Health, including FJ Labs, Gaingels, Calm Ventures and Tribe Capital. By type, the record holds 8 venture capital firms and 2 hedge funds.
About Hone Health
Developer of a telemedicine kit designed to help men and women lead longer, healthier lives. The company offers consulting services for anti-aging treatments and allows users to monitor their blood with the help of professional doctors through its FDA-approved testing system to book personalized treatment, enabling consumers to track their hormonal changes to get them treated affordably.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2020
- Employees
- 100
- Website
- honehealth.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.